IO Biotech Statistics

Total Valuation

IO Biotech has a market cap or net worth of $50.79 million. The enterprise value is -$27.37 million.

Market Cap	50.79M
Enterprise Value	-27.37M

Important Dates

The last earnings date was Tuesday, November 12, 2024, before market open.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

IO Biotech has 65.88 million shares outstanding. The number of shares has increased by 92.75% in one year.

Current Share Class	65.88M
Shares Outstanding	65.88M
Shares Change (YoY)	+92.75%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.23%
Owned by Institutions (%)	18.56%
Float	27.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.70
P/TBV Ratio	0.70
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.37, with a Debt / Equity ratio of 0.03.

Current Ratio	5.37
Quick Ratio	5.05
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -78.50% and return on invested capital (ROIC) is -51.33%.

Return on Equity (ROE)	-78.50%
Return on Assets (ROA)	-45.91%
Return on Capital (ROIC)	-51.33%
Revenue Per Employee	n/a
Profits Per Employee	-$1.33M
Employee Count	68
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, IO Biotech has paid $1.35 million in taxes.

Income Tax	1.35M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -49.28% in the last 52 weeks. The beta is 0.27, so IO Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.27
52-Week Price Change	-49.28%
50-Day Moving Average	0.99
200-Day Moving Average	1.26
Relative Strength Index (RSI)	39.57
Average Volume (20 Days)	381,114

Short Selling Information

The latest short interest is 46,500, so 0.07% of the outstanding shares have been sold short.

Short Interest	46,500
Short Previous Month	85,152
Short % of Shares Out	0.07%
Short % of Float	0.17%
Short Ratio (days to cover)	1.89

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-96.42M
Pretax Income	-87.64M
Net Income	-90.34M
EBITDA	-96.17M
EBIT	-96.42M
Earnings Per Share (EPS)	-$1.37

Full Income Statement

Balance Sheet

The company has $80.19 million in cash and $2.02 million in debt, giving a net cash position of $78.17 million or $1.19 per share.

Cash & Cash Equivalents	80.19M
Total Debt	2.02M
Net Cash	78.17M
Net Cash Per Share	$1.19
Equity (Book Value)	72.57M
Book Value Per Share	1.10
Working Capital	70.19M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$85.52 million and capital expenditures -$145,000, giving a free cash flow of -$85.66 million.

Operating Cash Flow	-85.52M
Capital Expenditures	-145,000
Free Cash Flow	-85.66M
FCF Per Share	-$1.30

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

IO Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-92.75%
Shareholder Yield	-92.75%
Earnings Yield	-177.86%
FCF Yield	-168.65%

Analyst Forecast

The average price target for IO Biotech is $9.33, which is 1,110.12% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.33
Price Target Difference	1,110.12%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1